Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
188 studies found for:    cgms, type 2
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Device: Continuous Glucose Monitoring (CGM)
2 Unknown  Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Device: Continuous Glucose Monitor;   Device: Glucometer
3 Completed Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring
Condition: Type 2 Diabetes
Interventions: Other: SMBG to guide clinical decisions;   Other: SMBG and CGM
4 Completed Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study
Condition: Type 2 Diabetes Mellitus
Intervention: Device: CGMS with an insulin pump using rapid acting insulin
5 Recruiting A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
Condition: Haemodialyzed, Type 2 Diabetes
Interventions: Drug: Vildagliptin (Galvus);   Drug: Insulin
6 Completed Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring;   Other: Continuous Glucose Monitoring;   Other: SMBG;   Other: SMBG With Knowledge
7 Completed Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
Condition: Type 2 Diabetes Mellitus
8 Completed Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control
Condition: Diabetes Mellitus, Type 2
Intervention: Device: 6-day Continuous Glucose Monitoring System
9 Recruiting SMBG Protocols Predicting Glucose Levels in Senior Diabetics With CAD
Conditions: Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions: Behavioral: SMBG;   Other: CGMS
10 Completed Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Treatment;   Exercise
Interventions: Behavioral: Acute aerobic exercise;   Behavioral: Acute aerobic-resistance exercise
11 Suspended Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring;   Other: Continuous Glucose Monitoring
12 Active, not recruiting Examining The Role of CGM in T2DM
Condition: Type 2 Diabetes, Non-Insulin Treated
Intervention: Other: Continuous Glucose Monitoring with treatment algorithm
13 Completed
Has Results
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: rosiglitazone-metformin fixed dose combination;   Drug: metformin + glimepiride
14 Completed
Has Results
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
15 Completed
Has Results
Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart 30;   Drug: biphasic human insulin 30;   Drug: metformin
16 Unknown  Healthy Moms, Healthy Babies
Conditions: Type 2 Diabetes Mellitus;   Gestational Diabetes
Interventions: Device: Continuous Glucose Monitoring;   Device: Glucose Meter
17 Completed CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
Condition: Type 2 Diabetes
18 Recruiting Efficacy of Sitagliptin and Glibenclamide on the Glucose Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Glibenclamide
19 Recruiting Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin;   Drug: Glimepiride;   Drug: Metformin
20 Completed Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition
Conditions: Diabetes Mellitus, Type 2;   Diabetic Blood Glucose Monitoring

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years